“PERSONALIZED THERAPY IN CARDIOLOGY: THE ROLE OF PHARMACOGENETICS AND BIOMARKERS IN THE SELECTION OF ANTIHYPERTENSIVE AND ANTIPLATELET AGENTS - POTENTIAL AND LIMITATIONS OF IMPLEMENTATION”. 2026. Genetics and Molecular Research, May. https://doi.org/10.4238/z3e7ft80.